Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01222481 · ClinicalTrials.gov registry record

Comprehensive Assessment of Head and Neck Cancer Survivors

A clinical trial of Head and Neck Cancer, sponsored by Jay F. Piccirillo, MD.

Completed
Registry status
15
Enrollment target
2
Study locations

NCT01222481 is a study of Head and Neck Cancer that has completed, run by Jay F. Piccirillo, MD. The registered enrollment target is 15 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01222481, a study of Head and Neck Cancer, has completed, sponsored by Jay F. Piccirillo, MD.

COMPLETED
Registry status
15 participants
Enrollment target
2
Study locations

Study Summary

Cancer survivorship has dramatically improved within the last four decades and a greater number of Americans are living after cancer diagnosis. An increase in the number of survivors has highlighted the need to investigate the quality of life experienced by these survivors. While Survivorship research has improved our understanding of the challenges faced by some cancer survivors, there is a paucity of research on the functional and cognitive health status of head and neck cancer survivors. The purpose of this study is to evaluate the functional and cognitive changes that occur in head and neck cancer patients as a result of cancer treatment, in an attempt to increase our understanding of the complex interactions between cancer treatment, comorbid health ailments and quality of life.

Conditions Studied

Study Locations (2)

Alabama

  • University of Alabama at Birmingham - Birmingham

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2009-07
Est. Completion 2012-02

Sponsor

Jay F. Piccirillo, MD

2 total trials

What the Registry Record Tells You About NCT01222481

The ClinicalTrials.gov registry entry for NCT01222481 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (94% lower). The listed sponsor is Jay F. Piccirillo, MD, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT01222481 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, Missouri.

Frequently Asked Questions

What is clinical trial NCT01222481 about?

NCT01222481 is a clinical study titled "Comprehensive Assessment of Head and Neck Cancer Survivors". Cancer survivorship has dramatically improved within the last four decades and a greater number of Americans are living after cancer diagnosis. An increase in the number of survivors has highlighted the need to investigate the quality of life experienced by these survivors. While Survivorship resear...

What is the current status of trial NCT01222481?

This trial is currently completed. The enrollment target is 15 participants. The study started on 2009-07. Estimated completion is 2012-02.

What conditions does trial NCT01222481 study?

This clinical trial studies the following conditions: Head and Neck Cancer.

Who is sponsoring clinical trial NCT01222481?

This trial is sponsored by Jay F. Piccirillo, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01222481 being conducted?

This trial has 2 study locations across Alabama, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.